Kiora Pharmaceuticals Inc (KPRX) News & Events

$2.620

-0.039 (-1.50%)At close

KPRX News

Kiora Pharmaceuticals to Participate in Investor Fireside Chat

Kiora Pharmaceuticals Q1 Financial Analysis

KIORA PHARMACEUTICALS INC Reports Q1 Loss of $0.58 Per Share in SEC Filing

Kiora Pharmaceuticals Secures $24 Million Financing to Advance Eye Disease Treatments

KIORA PHARMACEUTICALS INC TO OFFER 438,471 COMMON STOCK SHARES THROUGH PRIVATE PLACEMENT - SEC FILING

Kiora Pharmaceuticals Reports FY 2025 Financial Results

Kiora Pharmaceuticals Joins RARE-X Vision Consortium Promoting Collaboration and Development of New Treatments for Rare Ocular Disorders

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

HC Wainwright & Co. Reiterates Buy on Kiora Pharmaceuticals, Maintains $10 Price Target

Kiora Pharmaceuticals gets approval to initiate mid-stage trial for eye disorder treatment

5/18 16:40

Kiora Pharmaceuticals Files to Sell 11.8M Shares of Common Stock

Kiora Pharmaceuticals files to sell 11.8M shares of common stock for holders

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.